Over recent decades there has been a significant increase in the annual incidence of neuroendocrine tumors of the pancreas (PanNETs), from 0.4 to 0.8 per 100,000 inhabitants, due to a more widespread use of more sensitive imaging techniques (cross-sectional and functional imaging).